Detalles de la búsqueda
1.
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer
; 23(1): 1080, 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946136
2.
Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.
BMC Immunol
; 22(1): 38, 2021 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34144673
3.
Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.
J Neurooncol
; 137(2): 429-438, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29374810
4.
Evaluation of the quality of the information received during head and neck cancer announcement: Prospective two-center study.
Head Neck
; 42(8): 1800-1810, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32091638
5.
Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol.
BMJ Open
; 10(9): e038391, 2020 09 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32967883
6.
Limbs and trunk soft tissue sarcoma systematic local and remote monitoring by MRI and thoraco-abdomino-pelvic scanner: A single-centre retrospective study.
Eur J Surg Oncol
; 45(7): 1274-1280, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765271
7.
Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Technol Cancer Res Treat
; 17: 1533033818806498, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30343637
Resultados
1 -
7
de 7
1
Próxima >
>>